Gefitero 250 Mg Tablet

Description

Gefitero 250mg Tablet is a medication containing Gefitinib as its active ingredient. Gefitinib is a targeted therapy drug that works by inhibiting the epidermal growth factor receptor (EGFR) tyrosine kinase. This inhibition blocks the signaling pathways that promote cancer cell growth and survival. Gefitero 250mg Tablet is primarily indicated for the treatment of certain types of non-small cell lung cancer (NSCLC) in patients whose tumors have specific EGFR mutations. It is typically administered orally once daily. Common side effects may include diarrhea, rash, nausea, vomiting, dry skin, and fatigue. Less common but serious side effects can occur, so it is crucial to discuss any concerns with a healthcare professional. Gefitero 250mg Tablet should be stored at room temperature, away from moisture and heat, and out of reach of children.